These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 10670455)

  • 21. Immunolabelling of the 5-HT 3B receptor subunit in the central and peripheral nervous systems in rodents.
    Doucet E; Latrémolière A; Darmon M; Hamon M; Emerit MB
    Eur J Neurosci; 2007 Jul; 26(2):355-66. PubMed ID: 17650111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Localization of 5-HT3 receptors in the rat spinal cord: immunohistochemistry and in situ hybridization.
    Kia HK; Miquel MC; McKernan RM; Laporte AM; Lombard MC; Bourgoin S; Hamon M; Vergé D
    Neuroreport; 1995 Jan; 6(2):257-61. PubMed ID: 7756605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and radiolabeling of (S)-4-amino-5-iodo-2-methoxy-N-(1-azabicyclo[2.2.2]oct-3-yl)benzamide, the active enantiomer of [125I]iodozacopride, and re-evaluation of its 5-HT3 receptor affinity.
    Hewlett WA; de Paulis T; Mason NS; Schmidt DE; Trivedi BL; Zhang ZJ; Ebert MH
    Chem Pharm Bull (Tokyo); 1997 Dec; 45(12):2079-84. PubMed ID: 9433779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distribution of S(-)-zacopride-insensitive [125I]R(+)-zacopride binding sites in the rat brain and peripheral tissues.
    Ge J; Barnes JM; Towers P; Barnes NM
    Eur J Pharmacol; 1997 Aug; 332(3):307-12. PubMed ID: 9300265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Developmental changes in the differential expression of two serotonin 5-HT3 receptor splice variants in the rat.
    Miquel MC; Emerit MB; Gingrich JA; Nosjean A; Hamon M; el Mestikawy S
    J Neurochem; 1995 Aug; 65(2):475-83. PubMed ID: 7616200
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Importance of the C-terminus of the human 5-HT3A receptor subunit.
    Butler AS; Lindesay SA; Dover TJ; Kennedy MD; Patchell VB; Levine BA; Hope AG; Barnes NM
    Neuropharmacology; 2009 Jan; 56(1):292-302. PubMed ID: 18786552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of polyclonal anti-D2 dopamine receptor antibodies using sequence-specific peptides.
    Boundy VA; Luedtke RR; Artymyshyn RP; Filtz TM; Molinoff PB
    Mol Pharmacol; 1993 May; 43(5):666-76. PubMed ID: 8502224
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterisation of axon terminals in the rat dorsal horn that are immunoreactive for serotonin 5-HT3A receptor subunits.
    Maxwell DJ; Kerr R; Rashid S; Anderson E
    Exp Brain Res; 2003 Mar; 149(1):114-24. PubMed ID: 12592509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Localization of mu-opioid receptor-like immunoreactivity in the central components of the vagus nerve: a light and electron microscope study in the rat.
    Nomura S; Ding YQ; Kaneko T; Li JL; Mizuno N
    Neuroscience; 1996 Jul; 73(1):277-86. PubMed ID: 8783249
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular cloning, functional expression, and pharmacological characterization of 5-hydroxytryptamine3 receptor cDNA and its splice variants from guinea pig.
    Lankiewicz S; Lobitz N; Wetzel CH; Rupprecht R; Gisselmann G; Hatt H
    Mol Pharmacol; 1998 Feb; 53(2):202-12. PubMed ID: 9463477
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular determinants of (+)-tubocurarine binding at recombinant 5-hydroxytryptamine3A receptor subunits.
    Hope AG; Belelli D; Mair ID; Lambert JJ; Peters JA
    Mol Pharmacol; 1999 Jun; 55(6):1037-43. PubMed ID: 10347245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Localization of 5-HT2A receptor in rat cerebral cortex and olfactory system revealed by immunohistochemistry using two antibodies raised in rabbit and chicken.
    Hamada S; Senzaki K; Hamaguchi-Hamada K; Tabuchi K; Yamamoto H; Yamamoto T; Yoshikawa S; Okano H; Okado N
    Brain Res Mol Brain Res; 1998 Mar; 54(2):199-211. PubMed ID: 9555012
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular determinants of picrotoxin inhibition of 5-hydroxytryptamine type 3 receptors.
    Das P; Dillon GH
    J Pharmacol Exp Ther; 2005 Jul; 314(1):320-8. PubMed ID: 15814570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences in the central nervous system distribution and pharmacology of the mouse 5-hydroxytryptamine-6 receptor compared with rat and human receptors investigated by radioligand binding, site-directed mutagenesis, and molecular modeling.
    Hirst WD; Abrahamsen B; Blaney FE; Calver AR; Aloj L; Price GW; Medhurst AD
    Mol Pharmacol; 2003 Dec; 64(6):1295-308. PubMed ID: 14645659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Labelling of 5-HT3 receptor recognition sites in the rat brain using the agonist radioligand [3H]meta-chlorophenylbiguanide.
    Steward LJ; West KE; Kilpatrick GJ; Barnes NM
    Eur J Pharmacol; 1993 Oct; 243(1):13-8. PubMed ID: 8253120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 5-HT3 receptors in the rat central nervous system are mainly located on nerve fibres and terminals.
    Kidd EJ; Laporte AM; Langlois X; Fattaccini CM; Doyen C; Lombard MC; Gozlan H; Hamon M
    Brain Res; 1993 May; 612(1-2):289-98. PubMed ID: 8330206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibodies against the extracellular domain of the 5-HT3 receptor label both native and recombinant receptors.
    Spier AD; Wotherspoon G; Nayak SV; Nichols RA; Priestley JV; Lummis SC
    Brain Res Mol Brain Res; 1999 Apr; 67(2):221-30. PubMed ID: 10216220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cannabinoid CB1 receptor and serotonin 3 receptor subunit A (5-HT3A) are co-expressed in GABA neurons in the rat telencephalon.
    Morales M; Wang SD; Diaz-Ruiz O; Jho DH
    J Comp Neurol; 2004 Jan; 468(2):205-16. PubMed ID: 14648680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Naturally occurring variations in the human 5-HT3A gene profoundly impact 5-HT3 receptor function and expression.
    Krzywkowski K; Jensen AA; Connolly CN; Bräuner-Osborne H
    Pharmacogenet Genomics; 2007 Apr; 17(4):255-66. PubMed ID: 17496724
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High yield and efficient expression and purification of the human 5-HT3A receptor.
    Wu ZS; Cui ZC; Cheng H; Fan C; Melcher K; Jiang Y; Zhang CH; Jiang HL; Cong Y; Liu Q; Xu HE
    Acta Pharmacol Sin; 2015 Aug; 36(8):1024-32. PubMed ID: 26073329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.